Enzymes are vital to metabolism and drive countless biological processes in humans, plants, and industry. Yet, when ...

During a live event, Mark Yarchoan, MD, and participants reviewed adverse event management for 3 different combination ...

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological ...

In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

New research suggests that COVID-19 can lead to protein build-up similar to that seen in Alzheimer's patients, not just in ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its inflammatory flare-ups.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

A new drug was shown to significantly reduce tumor growth in lab studies by up to 77% for melanoma and colorectal cancers.

FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...